Transparency Initiative

At Calea and Fresenius Kabi we care for the life of patients worldwide.  To fulfill our commitment to benefit critically and chronically ill patients, collaborating with physicians, hospitals and patient organisations is essential.  These partnerships are not only required to develop products that best meet clinical needs.  Healthcare Professionals are provided with the necessary expertise and education to be able to safely and effectively use our drugs and medical devices.  In supporting medical research and education Fresenius Kabi contributes to patient safety and increased access to new technologies and services.

We expect transparency, accountability and high ethical standards from ourselves – and our stakeholders expect the same from us.  Their trust is rewarded by acting with utmost integrity and responsibility.  We believe that transparency is key to safeguard the integrity of these partnerships to the public and remain trusted.

Being member of various industry associations in the countries we are operating in, we have committed ourselves to disclose certain value transfers to Healthcare Professionals, Healthcare Organisations and selected patient care organisations in these countries.

In each such interaction, we respect the obligation of Healthcare Professionals to make independent treatment decisions.

We welcome any questions or remarks at

UK Carbon Reduction Plan 2022

Supplier name: Calea UK Limited, United Kingdom (UK)

To read about our UK Carbon Reduction Plan click here

HPN Homecare team call: 0800 121 8300
Biosimilars Homecare team call: 0800 090 2461